Naiwanel 28 0.02 mg / 3 mg Norge - norsk - Statens legemiddelverk

naiwanel 28 0.02 mg / 3 mg

medical valley - etinyløstradiol / drospirenon - tablett, filmdrasjert - 0.02 mg / 3 mg

Amorina 0.25 mg / 0.035 mg Norge - norsk - Statens legemiddelverk

amorina 0.25 mg / 0.035 mg

effik s.a - norgestimat / etinyløstradiol - tablett - 0.25 mg / 0.035 mg

Teriflunomide Mylan Den europeiske union - norsk - EMA (European Medicines Agency)

teriflunomide mylan

mylan pharmaceuticals limited - teriflunomide - multippel sklerose, relapsing-remitting - immunsuppressive - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).

Teriflunomide Accord Den europeiske union - norsk - EMA (European Medicines Agency)

teriflunomide accord

accord healthcare s.l.u. - teriflunomide - multippel sklerose, relapsing-remitting - immunosuppressants, selektiv immunosuppressants - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

Brintellix 10 mg Norge - norsk - Statens legemiddelverk

brintellix 10 mg

farmagon - vortioksetinhydrobromid - tablett, filmdrasjert - 10 mg

Fycompa 6 mg Norge - norsk - Statens legemiddelverk

fycompa 6 mg

orifarm as - perampanel - tablett, filmdrasjert - 6 mg

Brintellix Den europeiske union - norsk - EMA (European Medicines Agency)

brintellix

h. lundbeck a/s - vortioxetine - depressiv lidelse, major - psychoanaleptics, - behandling av alvorlige depressive episoder hos voksne.

Entresto Den europeiske union - norsk - EMA (European Medicines Agency)

entresto

novartis europharm limited - sacubitril, valsartan - hjertefeil - angiotensin ii antagonister, andre kombinasjoner, agenter som handler på renin-angiotensin-systemet - paediatric heart failureentresto is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction. adult heart failureentresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.

Neparvis Den europeiske union - norsk - EMA (European Medicines Agency)

neparvis

novartis europharm limited - sacubitril, valsartan - hjertefeil - agenter som virker på renin-angiotensinsystemet - paediatric heart failureneparvis is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction (see section 5. adult heart failureneparvis is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction (see section 5.

Thalidomide BMS (previously Thalidomide Celgene) Den europeiske union - norsk - EMA (European Medicines Agency)

thalidomide bms (previously thalidomide celgene)

bristol-myers squibb pharma eeig - thalidomid - multippelt myelom - immunsuppressive - thalidomide bms in combination with melphalan and prednisone as first line treatment of patients with untreated multiple myeloma, aged >/= 65 years or ineligible for high dose chemotherapy. thalidomide bms is prescribed and dispensed according to the thalidomide celgene pregnancy prevention programme (see section 4.